Site Search:

A browser that supports JavaScript is required to submit the NOVA site search form and to display search results.

Audience Navigation:

Topic Navigation:

Breadcrumb Navigation:

Home > About NOVA > Emergency Preparedness > Pandemic Flu > Information

H1N1 Overview

Fast Facts

  • CDC expects a surge of illnesses associated with H1N1 in the fall.
  • Novel H1N1 is capable of causing severe disease and death, especially among people with underlying health problems that are associated with a high risk of influenza complications.
  • Novel H1N1 affects young people disproportionately with few cases among the elderly.
  • Novel H1N1 flu is showing antiviral resistance to oseltamivir (Tamiflu®).

What NOVA Is Doing to Help Protect Our Students, Faculty and Staff

  • Implementing policies that encourage people to stay home when they're sick.
  • Encouraging infection control practices.
    • Displaying educational posters.
    • Providing alcohol-based hand sanitizer and sufficient facilities for hand washing.
    • Providing disinfectant and disposable towels to employees to clean their work surfaces.
  • Sharing flu-related policies and plans and clearly communicating expectations.

Read More

What can NOVA do to anticipate and respond to the impact of novel H1N1 flu on operations?

  • Determine who will be responsible for responding to ill individuals in the workplace, either through an established health clinic or as a first aid duty.
  • Make sure you have up-to-date continuity of operations and emergency communications plans in place.
  • Develop platforms (e.g., hotlines, dedicated websites) for communicating novel H1N1 flu status and actions to employees, vendors, suppliers and customers.

Read More

Who should receive the novel H1N1 vaccine?
On July 29, 2009, the Advisory Committee on Immunization Practices, an advisory committee to CDC, recommended that the H1N1 flu vaccine be made available first to the following five groups:

  • Pregnant women
  • Health care workers and emergency medical responders
  • People caring for infants under 6 months of age
  • Children and young adults from 6 months to 24 years
  • People aged 25 to 64 years with underlying medical conditions (e.g. asthma, diabetes)

Vaccine trials are currently underway. CDC anticipates that a vaccine will be available in mid to late October. The novel H1N1 vaccine is not intended to replace the seasonal flu vaccine; it is intended to be used along-side seasonal flu vaccine. CDC is encouraging people to get vaccinated against seasonal influenza as soon as vaccines become available in their communities (as early as August for some).

Read More

Alerts

pub safety spacer
Emergency Planning Blog
Online Training
Campus Safety Video
Public Safety Newsletter
College Security Reports
Archived Reports